ASHBURN, Va., March 13, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced recent corporate accomplishments and provided an update on its fourth quarter and full-year 2024 progress. Quoin CEO Michael Myers… Read More..

ASHBURN, Va., March 06, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to release its financial results for the fourth quarter and full year ended December 31, 2024,… Read More..

MILTON, N.Y., March 05, 2025 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (NASDAQ: SOTK), a leading developer and manufacturer of ultrasonic coating systems, is pleased to announce the promotion of Chris Cichetti to the position of Chief Operating Officer (COO). Chris Cichetti joined Sono-Tek in 2005 as an Electrical Engineer and has… Read More..